Albania vs Tonga: Cause of death, by non-communicable diseases, ages 5-14, female
Albania
48.8%
in 2021
Tonga
47.3%
in 2021
Albania rank
65th
Tonga rank
67th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Albania
- Tonga
How they compare
Albania currently reports 48.8% against 47.3% in Tonga, a difference of 1.5%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Tonga ahead.
Albania ranks 65th and Tonga ranks 67th of 184 countries.
Across the 3 decades both report, Albania averaged higher in 1 and Tonga in 2.
Head to head by decade
| Decade | Albania | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.8% | 38.9% | 3.1% | Tonga |
| 2010s | 44.7% | 44.9% | 0.2% | Tonga |
| 2020s | 48.9% | 47.0% | 1.8% | Albania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Albania or Tonga?
- Albania, at 48.8% against 47.3% in Tonga as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Albania and Tonga?
- 1.5%, with Albania ahead.
- How many years of comparable data are there for Albania and Tonga?
- 6 years are reported by both, from 2000 to 2021.
- How do Albania and Tonga rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Albania ranks 65th and Tonga ranks 67th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.